Market Exclusive

Analyst Activity – B. Riley Initiates Coverage On Regulus Therapeutics (NASDAQ:RGLS) (NASDAQ:RGLS) With a Neutral

Analyst Ratings For Regulus Therapeutics (NASDAQ:RGLS) (NASDAQ:RGLS)

Today, B. Riley initiated coverage on Regulus Therapeutics (NASDAQ:RGLS) (NASDAQ:RGLS) with a Neutral with a price target of $1.00.

Some recent analyst ratings include

Recent Insider Trading Activity For Regulus Therapeutics (NASDAQ:RGLS) (NASDAQ:RGLS)
Regulus Therapeutics (NASDAQ:RGLS) (NASDAQ:RGLS) has insider ownership of 4.80% and institutional ownership of 53.72%.

Recent Trading Activity for Regulus Therapeutics (NASDAQ:RGLS) (NASDAQ:RGLS)
Shares of Regulus Therapeutics (NASDAQ:RGLS) closed the previous trading session at 0.79 down -0.01 1.23% with 0.7929999828338623 shares trading hands.

Exit mobile version